MedWatch - The FDA Safety Information and Adverse Event Reporting ProgramAtar Extension Cables by Oscor: Recall - Cable Separating from ConnectorAUDIENCE: Cardiology ISSUE: During the use of some Atar extension cables, the cable was separating from the connector at the proximal end. The analysis of the returned devices revealed a change in the manufacturing sequence attributed to the connector and wire separation, causing a fracture of the conductor cable from extensive use. This event resulted in cable malfunction, causing interruption of the pacing system. Oscor received a total of 66 complaints related to that failure mode, of which 5 resulted in patient injuries. No deaths were reported; however the risk for possible injury is a concern if the cable separates during use. For pacing dependent patients, an interruption of pacing system could result in serious injury or death if not detected. Continuous monitoring is required. BACKGROUND: The Atar cable is an extension cable with connector(s) on both sides, designed to connect with various receptacles or cables/leads, depending on the instrument being used. The extension cable is intended to connect an electrode/lead from a patient or another cable to a diagnostic machine or an external pacemaker. RECOMMENDATION: Customers may contact Oscor’s Customer Service Group, Monday to Friday from 8:30AM to 6:00PM Eastern Time at 727-937-2511 or via email at atar@xxxxxxxxx. Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:
View the MedWatch Safety Alert, including links to the recall notice, at: https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm566006 You are encouraged to report all serious adverse events and product quality problems to FDA MedWatch at www.fda.gov/medwatch/report.htm Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit subscriberhelp.govdelivery.com. This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
|
